Benjamin Burnett

Stock Analyst at Wells Fargo

(3.81)
# 669
Out of 5,148 analysts
96
Total ratings
55.56%
Success rate
8.54%
Average return

Stocks Rated by Benjamin Burnett

Amphastar Pharmaceuticals
Feb 27, 2026
Maintains: Overweight
Price Target: $34$30
Current: $21.01
Upside: +42.79%
Alkermes
Feb 26, 2026
Maintains: Overweight
Price Target: $37$43
Current: $30.25
Upside: +42.15%
Axsome Therapeutics
Feb 24, 2026
Maintains: Overweight
Price Target: $193$202
Current: $166.38
Upside: +21.41%
Insmed
Feb 20, 2026
Maintains: Overweight
Price Target: $234$208
Current: $146.32
Upside: +42.15%
Centessa Pharmaceuticals
Nov 13, 2025
Maintains: Overweight
Price Target: $30$35
Current: $26.51
Upside: +32.03%
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5$3
Current: $1.50
Upside: +100.00%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53$49
Current: $60.77
Upside: -19.37%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83$122
Current: $114.05
Upside: +6.97%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66$69
Current: $28.69
Upside: +140.50%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63$68
Current: $33.04
Upside: +105.81%
Maintains: Hold
Price Target: $4.4$4.6
Current: $2.65
Upside: +73.58%
Maintains: Hold
Price Target: $120$58
Current: $4.91
Upside: +1,071.08%
Maintains: Buy
Price Target: $690$780
Current: $4.33
Upside: +17,913.86%
Maintains: Overweight
Price Target: $48$49
Current: $42.55
Upside: +15.16%
Maintains: Overweight
Price Target: $8$7
Current: $3.04
Upside: +130.64%
Maintains: Equal-Weight
Price Target: $423$466
Current: $513.82
Upside: -9.31%
Maintains: Equal-Weight
Price Target: $282$305
Current: $330.59
Upside: -7.74%
Maintains: Overweight
Price Target: $93$86
Current: $66.37
Upside: +29.58%
Maintains: Overweight
Price Target: $29$27
Current: $13.85
Upside: +94.95%
Initiates: Overweight
Price Target: $43
Current: $28.37
Upside: +51.57%
Maintains: Overweight
Price Target: $65$45
Current: $23.02
Upside: +95.48%
Maintains: Overweight
Price Target: $7$9
Current: $6.01
Upside: +49.75%
Maintains: Overweight
Price Target: $26$23
Current: $13.91
Upside: +65.35%
Maintains: Buy
Price Target: $78$64
Current: $101.62
Upside: -37.02%
Maintains: Buy
Price Target: $90$94
Current: $66.54
Upside: +41.27%
Maintains: Buy
Price Target: $7$10
Current: $3.62
Upside: +176.24%
Reiterates: Buy
Price Target: $25
Current: $3.79
Upside: +559.63%
Upgrades: Buy
Price Target: $330$360
Current: $68.36
Upside: +426.62%
Initiates: Hold
Price Target: $16
Current: $0.43
Upside: +3,621.80%